From active surveillance to surgery and image-guided therapies, the management of thyroid cancer continues to evolve.

How are you integrating emerging evidence and minimally invasive approaches into your practice? What challenges, controversies, or successes have shaped your experience?

Join the conversation and share your perspectives with the NASIT community.